{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:26:22Z","timestamp":1791901582648,"version":"4.3.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aims to develop and validate a nomogram for predicting 1- and 2-year generalization probabilities in patients with ocular myasthenia gravis (OMG).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In total, 501 eligible patients with OMG treated at seven tertiary hospitals in China between January 2015 and May 2019 were included. The primary outcome measure was disease generalization. A nomogram for predicting 1- and 2-year generalization probabilities was constructed using a stepwise Cox regression model. Nomogram performance was quantified using C-indexes and calibration curves. Two-year cumulative generalization rates were analyzed using the Kaplan\u2212Meier method for distinct nomogram-stratified risk groups. The clinical usefulness of the nomogram was evaluated using decision curve analysis (DCA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>The eligible patients were randomly divided into a development cohort (n=351, 70%) and a validation cohort (n=150, 30%). The final model included five variables: sex, onset age, repetitive nerve stimulation findings, acetylcholine receptor antibody test results, and thymic status. The model demonstrated good discrimination (C-indexes of 0.733 and 0.788 in the development and validation cohorts, respectively) and calibration, with good agreement between actual and nomogram-estimated generalization probabilities. Kaplan\u2212Meier curves revealed higher 2-year cumulative generalization rates in the high-risk group than that in the low-risk group. DCA demonstrated a higher net benefit of nomogram-assisted decisions compared to treatment of all patients or none.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The nomogram model can predict 1- and 2-year generalization probabilities in patients with OMG and stratified these patients into distinct generalization risk groups. The nomogram has potential to aid neurologists in selecting suitable patients for initiating immunotherapy and for enrolment in clinical trials of risk-modifying treatments.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.895007","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T15:39:51Z","timestamp":1657208391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhe","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songdi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20950","article-title":"Lifetime Course of Myasthenia Gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410140504","article-title":"Prognosis of Ocular Myasthenia","volume":"14","author":"Bever","year":"1983","journal-title":"Ann Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51317.x","article-title":"The Course of Myasthenia Gravis and Therapies Affecting Outcome","volume":"505","author":"Grob","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5120-8","article-title":"Ocular Myasthenia Gravis: Treatment Successes and Failures in Patients With Long-Term Follow-Up","volume":"256","author":"Kupersmith","year":"2009","journal-title":"J Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1996.00550080128020","article-title":"Beneficial Effects of Corticosteroids on Ocular Myasthenia Gravis","volume":"53","author":"Kupersmith","year":"1996","journal-title":"Arch Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/00041327-200312000-00002","article-title":"Immunotherapy of Ocular Myasthenia Gravis Reduces Conversion to Generalized Myasthenia Gravis","volume":"23","author":"Mee","year":"2003","journal-title":"J\u00a0Neuro-Ophthalmology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2003.08.017","article-title":"The Effect of Prednisone on the Progression From Ocular to Generalized Myasthenia Gravis","volume":"217","author":"Monsul","year":"2004","journal-title":"J Neurol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.62.2.156","article-title":"Ocular Myasthenia Gravis: Response to Long-Term Immunosuppressive Treatment","volume":"62","author":"Sommer","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12057","article-title":"The Effect of Early Prednisolone Treatment on the Generalization Rate in Ocular Myasthenia Gravis","volume":"20","author":"Zach","year":"2013","journal-title":"Eur J Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01129-z","article-title":"Thymectomy and Risk of Generalization in Patients With Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study","volume":"18","author":"Li","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2006.05.110","article-title":"Outcomes After 151 Extended Transcervical Thymectomies for Myasthenia Gravis","volume":"82","author":"Shrager","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.4.332","article-title":"Thymectomy in Myasthenia With Pure Ocular Symptoms","volume":"48","author":"Schumm","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903518107","article-title":"Immunosuppressive Therapies in Myasthenia Gravis","volume":"43","author":"Sanders","year":"2010","journal-title":"Autoimmunity"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.05.023","article-title":"Prognosis of Ocular Myasthenia in Korea: A Retrospective Multicenter Analysis of 202 Patients","volume":"273","author":"Hong","year":"2008","journal-title":"J Neurol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of Generalized Disease at 2 Years in Patients With Ocular Myasthenia Gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01139-x","article-title":"If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it","volume":"18","author":"Cutter","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25983","article-title":"Low Conversion Rate of Ocular to Generalized Myasthenia Gravis in Singapore","volume":"57","author":"Teo","year":"2018","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-2000-6829","article-title":"Ocular Aspects of Myasthenia Gravis","volume":"20","author":"Barton","year":"2000","journal-title":"Semin Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40120-021-00292-x","article-title":"Risk Factors for Generalization in Patients With Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study","volume":"11","author":"Guo","year":"2021","journal-title":"Neurol Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.09.019","article-title":"Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody","volume":"209","author":"Apinyawasisuk","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12883-017-0857-7","article-title":"Clinical Predictors for the Prognosis of Myasthenia Gravis","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000507853","article-title":"Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China","volume":"83","author":"Feng","year":"2020","journal-title":"Eur Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/00207454.2017.1344237","article-title":"Factors Affecting Outcome in Ocular Myasthenia Gravis","volume":"128","author":"Mazzoli","year":"2018","journal-title":"Int J Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1444","article-title":"Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis","volume":"72","author":"Peeler","year":"2015","journal-title":"JAMA Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14036","article-title":"Rapid Improvement of Muscle Weakness Post-Thymectomy Indicates Good Long-Term Neurological Outcome in Patients With Ocular Myasthenia Gravis","volume":"26","author":"Geng","year":"2019","journal-title":"Eur J Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.03.010","article-title":"Prognosis of Ocular Myasthenia Gravis: Retrospective Multicenter Analysis","volume":"122","author":"Nagia","year":"2015","journal-title":"Ophthalmology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7992","article-title":"Minimum Sample Size for Developing a Multivariable Prediction Model: Part Ii - Binary and Time-To-Event Outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","article-title":"Calculating the Sample Size Required for Developing a Clinical Prediction Model","volume":"368","author":"Riley","year":"2020","journal-title":"Bmj"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15292","article-title":"Association of Immunosuppression Treatment With Generalization Among Patients With Ocular Myasthenia Gravis: A Propensity Score Analysis","volume":"29","author":"Ruan","year":"2022","journal-title":"Eur J Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1109\/TAC.1974.1100705","article-title":"A New Look at the Statistical Model Identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans automatic control"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.034","article-title":"Prognostic Nomogram for Patients With Unresectable Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization","volume":"63","author":"Xu","year":"2015","journal-title":"J Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj063","article-title":"The Inconsistency of \"Optimal\" Cutpoints Obtained Using Two Criteria Based on the Receiver Operating Characteristic Curve","volume":"163","author":"Perkins","year":"2006","journal-title":"Am J Epidemiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to Decision Curve Analysis, a Novel Method for Evaluating Diagnostic Tests, Prediction Models and Molecular Markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1159\/000487132","article-title":"Prognosis of Ocular Myasthenia Gravis in an Argentinian Population","volume":"79","author":"Aguirre","year":"2018","journal-title":"Eur Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2019.04.017","article-title":"Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study","volume":"205","author":"Hendricks","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-018-0943-7","article-title":"Antibody Profile May Predict Outcome in Ocular Myasthenia Gravis","volume":"118","author":"Galassi","year":"2018","journal-title":"Acta Neurol Belg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.52.10.1121","article-title":"The Natural Course of Myasthenia Gravis: A Long Term Follow Up Study","volume":"52","author":"Oosterhuis","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.895007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T15:39:53Z","timestamp":1657208393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.895007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2022.895007"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.895007","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"article-number":"895007"}}